Valchlor Gel
NDC Package 69639-120-01
Package Information
Valchlor (mechlorethamine hydrochloride) gel is a medication used on the skin to treat a certain type of cancer (cutaneous T-cell lymphoma). This formulation utilizes a gel delivery system. Marketed by Helsinn Therapeutics (u.s.), Inc., this product is identified by NDC 69639-120 and is authorized under FDA application NDA202317.
Identification & Billing
- RxCUI: 1437711 - mechlorethamine 0.016 % Topical Gel
- RxCUI: 1437711 - mechlorethamine 0.00016 MG/MG Topical Gel
- RxCUI: 1437713 - VALCHLOR 0.016 % Topical Gel
- RxCUI: 1437713 - mechlorethamine 0.00016 MG/MG Topical Gel [Valchlor]
- RxCUI: 1437713 - Valchlor 0.00016 MG/MG Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69639 - Helsinn Therapeutics (u.s.), Inc.
- 69639-120 - Valchlor
- 69639-120-01 - 1 TUBE in 1 CARTON / 60 g in 1 TUBE
- 69639-120 - Valchlor
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69639-120-01 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Valchlor, a human prescription drug labeled by Helsinn Therapeutics (u.s.), Inc.. This product is billed per "GM" gram and contains an estimated amount of 60 billable units per package. This gel is formulated for topical use and contains mechlorethamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Helsinn Therapeutics (u.s.), Inc. on November 08, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used on the skin to treat a certain type of cancer (cutaneous T-cell lymphoma). Mechlorethamine belongs to a class of drugs known as alkylating agents. It works by slowing or stopping the growth of cancer cells that cause the skin condition.
How is this Helsinn Therapeutics (u.s.), Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69639012001. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.